Ella (ulipristal acetate) NDC 50090-5422

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-5422Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-5422Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-5422-0	50090542200	1 BLISTER PACK in 1 CARTON (50090-5422-0) / 1 TABLET in 1 BLISTER PACKMarketed from Jan 6, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ella
Generic name (nonproprietary): ulipristal acetate
Active ingredients: Ulipristal acetate — 30 mg/1
Dosage form: Tablet
Route: Oral
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 022474
Marketing start: May 11, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Selective Progesterone Receptor Modulators (Mechanism)
Identifiers: Product ID 50090-5422_cb78d0c3-de38-40ed-a74b-8391b860e1cbSPL ID cb78d0c3-de38-40ed-a74b-8391b860e1cbSPL set ID e5f09468-7ac8-40ba-a85b-758a32f586c3RxCUI 1005924, 1005928UNII YF7V70N02B
Pharmacologic class: Progesterone Agonist/Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090542200 followed by a unit qualifier and the quantity

Package 50090-5422-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 6, 2023.

Indications (excerpt from the label)

Ella is a progesterone agonist/antagonist emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure [see Dosage and Administration (2.1) ] . E lla is not intended for routine use as a contraceptive. Ella is a progesterone agonist/antagonist emergency contraceptive indicated for prevention of pregnancy following unprotected intercourse or a known or suspected contraceptive failure. Ella is not intended for routine use as a contraceptive. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 022474

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 022474
Product	Strength	Form · route	Labeler	Product NDC
Ellaulipristal acetate	Ulipristal acetate 30 mg/1	TabletOral	PMI Branded Pharmaceuticals, Inc.	73302-456